

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.81785291 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 5.51314808 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.51314808 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.51314808 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.51314808 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.51314808 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.51314808 |
| 8 | negative regulation of interleukin-12 production (GO:0032695) | 5.29747766 |
| 9 | response to peptidoglycan (GO:0032494) | 5.29386736 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.17271920 |
| 11 | negative regulation of cell killing (GO:0031342) | 5.17271920 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 5.01539134 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 4.99635189 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.53628735 |
| 15 | detection of molecule of bacterial origin (GO:0032490) | 4.50402126 |
| 16 | cellular extravasation (GO:0045123) | 4.43227233 |
| 17 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.27246941 |
| 18 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.24910598 |
| 19 | regulation of gamma-delta T cell activation (GO:0046643) | 4.23013695 |
| 20 | detection of other organism (GO:0098543) | 4.22987697 |
| 21 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.14652025 |
| 22 | microglial cell activation (GO:0001774) | 4.10299391 |
| 23 | immunoglobulin mediated immune response (GO:0016064) | 4.06705857 |
| 24 | neutrophil activation (GO:0042119) | 3.99739604 |
| 25 | detection of external biotic stimulus (GO:0098581) | 3.92138822 |
| 26 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.92024490 |
| 27 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.88128506 |
| 28 | macrophage activation (GO:0042116) | 3.87498525 |
| 29 | granulocyte activation (GO:0036230) | 3.86278940 |
| 30 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.85250514 |
| 31 | detection of bacterium (GO:0016045) | 3.83317042 |
| 32 | response to host immune response (GO:0052572) | 3.81710570 |
| 33 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.81710570 |
| 34 | leukocyte aggregation (GO:0070486) | 3.76305544 |
| 35 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.71883355 |
| 36 | myeloid cell activation involved in immune response (GO:0002275) | 3.70386133 |
| 37 | germinal center formation (GO:0002467) | 3.62330301 |
| 38 | neutrophil mediated immunity (GO:0002446) | 3.60111866 |
| 39 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.55454255 |
| 40 | negative regulation of T cell mediated immunity (GO:0002710) | 3.55349497 |
| 41 | detection of biotic stimulus (GO:0009595) | 3.53835299 |
| 42 | response to muramyl dipeptide (GO:0032495) | 3.52216606 |
| 43 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.51911247 |
| 44 | respiratory burst (GO:0045730) | 3.48917428 |
| 45 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.47087399 |
| 46 | defense response to protozoan (GO:0042832) | 3.45708550 |
| 47 | regulation of mast cell degranulation (GO:0043304) | 3.45426535 |
| 48 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.43043355 |
| 49 | regulation of interferon-alpha production (GO:0032647) | 3.42991319 |
| 50 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.42280180 |
| 51 | response to host (GO:0075136) | 3.42280180 |
| 52 | response to host defenses (GO:0052200) | 3.42280180 |
| 53 | cellular response to type I interferon (GO:0071357) | 3.39592620 |
| 54 | type I interferon signaling pathway (GO:0060337) | 3.39592620 |
| 55 | response to type I interferon (GO:0034340) | 3.38650898 |
| 56 | positive regulation of mast cell activation (GO:0033005) | 3.38383345 |
| 57 | regulation of mast cell activation (GO:0033003) | 3.33220362 |
| 58 | positive regulation of interferon-alpha production (GO:0032727) | 3.29010837 |
| 59 | response to protozoan (GO:0001562) | 3.27629625 |
| 60 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.26561711 |
| 61 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.26550970 |
| 62 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.25486950 |
| 63 | T-helper 1 type immune response (GO:0042088) | 3.24577964 |
| 64 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.19939772 |
| 65 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.19356973 |
| 66 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.18655769 |
| 67 | B cell mediated immunity (GO:0019724) | 3.12461965 |
| 68 | response to interleukin-15 (GO:0070672) | 3.11683143 |
| 69 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.08477511 |
| 70 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.08089274 |
| 71 | myeloid leukocyte mediated immunity (GO:0002444) | 3.03245271 |
| 72 | positive regulation of B cell differentiation (GO:0045579) | 3.02900668 |
| 73 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.01425679 |
| 74 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.99912400 |
| 75 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.99197465 |
| 76 | positive regulation of mast cell degranulation (GO:0043306) | 2.99197465 |
| 77 | regulation of leukocyte degranulation (GO:0043300) | 2.98500008 |
| 78 | negative regulation of interleukin-6 production (GO:0032715) | 2.98302454 |
| 79 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.97589912 |
| 80 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.96158182 |
| 81 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.94978924 |
| 82 | leukocyte degranulation (GO:0043299) | 2.94148562 |
| 83 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.94052841 |
| 84 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.93452111 |
| 85 | regulation of antigen processing and presentation (GO:0002577) | 2.93359298 |
| 86 | myeloid leukocyte activation (GO:0002274) | 2.92534702 |
| 87 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.92425953 |
| 88 | positive regulation of interferon-beta production (GO:0032728) | 2.90805582 |
| 89 | neutrophil chemotaxis (GO:0030593) | 2.89979379 |
| 90 | regulation of tolerance induction (GO:0002643) | 2.89157432 |
| 91 | B cell receptor signaling pathway (GO:0050853) | 2.88674863 |
| 92 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.87324401 |
| 93 | positive regulation of antigen processing and presentation (GO:0002579) | 2.87261105 |
| 94 | neutrophil migration (GO:1990266) | 2.82425082 |
| 95 | regulation of interleukin-12 production (GO:0032655) | 2.81772731 |
| 96 | T cell migration (GO:0072678) | 2.81719010 |
| 97 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.80605229 |
| 98 | regulation of B cell differentiation (GO:0045577) | 2.79863599 |
| 99 | cellular response to interleukin-15 (GO:0071350) | 2.78857329 |
| 100 | negative regulation of innate immune response (GO:0045824) | 2.78254175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.15445210 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.21551554 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.84642754 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.98685939 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.67556754 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.62224699 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.51102983 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.41075502 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.25160618 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.08699199 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.94512878 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.88943099 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.79715372 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.62879295 |
| 15 | SPI1_23127762_ChIP-Seq_K562_Human | 2.57297357 |
| 16 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.55929701 |
| 17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.53967662 |
| 18 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.50614641 |
| 19 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.43492125 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.37836359 |
| 21 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.35622240 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.33920942 |
| 23 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.27132305 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.25294468 |
| 25 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.20636290 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 2.19212757 |
| 27 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.11500509 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.08859605 |
| 29 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.06906427 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.04584884 |
| 31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.98743724 |
| 32 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.98567540 |
| 33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.97954189 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.87240105 |
| 35 | MAF_26560356_Chip-Seq_TH1_Human | 1.86463324 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.78617393 |
| 37 | MYB_26560356_Chip-Seq_TH1_Human | 1.76907623 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74401692 |
| 39 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73901336 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.69085714 |
| 41 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.64568951 |
| 42 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.64560815 |
| 43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.61472602 |
| 44 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.60546604 |
| 45 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.60420489 |
| 46 | GATA3_26560356_Chip-Seq_TH2_Human | 1.52042483 |
| 47 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51852191 |
| 48 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.48092100 |
| 49 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.45800275 |
| 50 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.41850171 |
| 51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36777885 |
| 52 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.34730307 |
| 53 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33972610 |
| 54 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33507682 |
| 55 | MYC_22102868_ChIP-Seq_BL_Human | 1.32184710 |
| 56 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.29417184 |
| 57 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29405379 |
| 58 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26256983 |
| 59 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25633038 |
| 60 | MAF_26560356_Chip-Seq_TH2_Human | 1.25632348 |
| 61 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.25628007 |
| 62 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24336491 |
| 63 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23967318 |
| 64 | GATA1_19941826_ChIP-Seq_K562_Human | 1.21323411 |
| 65 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20981327 |
| 66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20671372 |
| 67 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.20164437 |
| 68 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19461655 |
| 69 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17695079 |
| 70 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15919648 |
| 71 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.13164165 |
| 72 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.12805222 |
| 73 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.12180372 |
| 74 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10575392 |
| 75 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08322339 |
| 76 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04897491 |
| 77 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.02487877 |
| 78 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.02306715 |
| 79 | GATA2_19941826_ChIP-Seq_K562_Human | 1.00338032 |
| 80 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.92762290 |
| 81 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92059413 |
| 82 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87696974 |
| 83 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.87036309 |
| 84 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.86722770 |
| 85 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.82958728 |
| 86 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81498184 |
| 87 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.78957863 |
| 88 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.78775520 |
| 89 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.78183262 |
| 90 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.74741327 |
| 91 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.72911359 |
| 92 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70803103 |
| 93 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.70131624 |
| 94 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.69977409 |
| 95 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.69936560 |
| 96 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.68011610 |
| 97 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.67379296 |
| 98 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.66382072 |
| 99 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.65345493 |
| 100 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.65082346 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.82670340 |
| 2 | MP0003303_peritoneal_inflammation | 4.59228614 |
| 3 | MP0003436_decreased_susceptibility_to | 3.97112856 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.67073281 |
| 5 | MP0002419_abnormal_innate_immunity | 3.09336573 |
| 6 | MP0009785_altered_susceptibility_to | 3.06410961 |
| 7 | MP0006082_CNS_inflammation | 2.94693144 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.87011617 |
| 9 | MP0005671_abnormal_response_to | 2.84968126 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.83502329 |
| 11 | MP0005025_abnormal_response_to | 2.78685001 |
| 12 | MP0001790_abnormal_immune_system | 2.74979120 |
| 13 | MP0005387_immune_system_phenotype | 2.74979120 |
| 14 | MP0001800_abnormal_humoral_immune | 2.70688209 |
| 15 | MP0002723_abnormal_immune_serum | 2.52028416 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.48572450 |
| 17 | MP0000685_abnormal_immune_system | 2.46438702 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.36364312 |
| 19 | MP0009278_abnormal_bone_marrow | 2.31766995 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.30601826 |
| 21 | MP0001819_abnormal_immune_cell | 2.29177165 |
| 22 | MP0009764_decreased_sensitivity_to | 2.19166403 |
| 23 | MP0001533_abnormal_skeleton_physiology | 2.17885488 |
| 24 | MP0003172_abnormal_lysosome_physiology | 2.11475924 |
| 25 | MP0005464_abnormal_platelet_physiology | 1.93824595 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 1.93686187 |
| 27 | MP0002405_respiratory_system_inflammati | 1.89370500 |
| 28 | MP0001845_abnormal_inflammatory_respons | 1.81733131 |
| 29 | MP0005451_abnormal_body_composition | 1.77857849 |
| 30 | MP0004947_skin_inflammation | 1.75836947 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.74354724 |
| 32 | MP0005397_hematopoietic_system_phenotyp | 1.74252275 |
| 33 | MP0001545_abnormal_hematopoietic_system | 1.74252275 |
| 34 | MP0004510_myositis | 1.72607300 |
| 35 | MP0000716_abnormal_immune_system | 1.70279029 |
| 36 | MP0005058_abnormal_lysosome_morphology | 1.69794224 |
| 37 | MP0002398_abnormal_bone_marrow | 1.62408410 |
| 38 | MP0003075_altered_response_to | 1.61723120 |
| 39 | MP0008469_abnormal_protein_level | 1.56042351 |
| 40 | MP0008260_abnormal_autophagy | 1.55058608 |
| 41 | MP0003828_pulmonary_edema | 1.53432023 |
| 42 | MP0003763_abnormal_thymus_physiology | 1.52307083 |
| 43 | MP0005310_abnormal_salivary_gland | 1.50050607 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.38609432 |
| 45 | MP0002998_abnormal_bone_remodeling | 1.34642043 |
| 46 | MP0009333_abnormal_splenocyte_physiolog | 1.33649148 |
| 47 | MP0000343_altered_response_to | 1.33278227 |
| 48 | MP0002722_abnormal_immune_system | 1.33276574 |
| 49 | MP0002429_abnormal_blood_cell | 1.31439834 |
| 50 | MP0008004_abnormal_stomach_pH | 1.31357595 |
| 51 | MP0001853_heart_inflammation | 1.31307580 |
| 52 | MP0003183_abnormal_peptide_metabolism | 1.29128334 |
| 53 | MP0005167_abnormal_blood-brain_barrier | 1.29127424 |
| 54 | MP0004883_abnormal_blood_vessel | 1.27229902 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.26186549 |
| 56 | MP0003690_abnormal_glial_cell | 1.25684227 |
| 57 | MP0003656_abnormal_erythrocyte_physiolo | 1.22213774 |
| 58 | MP0000569_abnormal_digit_pigmentation | 1.21759131 |
| 59 | MP0000604_amyloidosis | 1.20320952 |
| 60 | MP0000858_altered_metastatic_potential | 1.19628928 |
| 61 | MP0005164_abnormal_response_to | 1.17625892 |
| 62 | MP0002277_abnormal_respiratory_mucosa | 1.15135443 |
| 63 | MP0005166_decreased_susceptibility_to | 1.13477486 |
| 64 | MP0002332_abnormal_exercise_endurance | 1.12128153 |
| 65 | MP0002132_abnormal_respiratory_system | 1.11594022 |
| 66 | MP0003448_altered_tumor_morphology | 1.09241645 |
| 67 | MP0003866_abnormal_defecation | 1.08935792 |
| 68 | MP0009840_abnormal_foam_cell | 1.07156228 |
| 69 | MP0003195_calcinosis | 1.06091277 |
| 70 | MP0000703_abnormal_thymus_morphology | 0.98180218 |
| 71 | MP0001851_eye_inflammation | 0.95986740 |
| 72 | MP0006054_spinal_hemorrhage | 0.95087551 |
| 73 | MP0004381_abnormal_hair_follicle | 0.94998754 |
| 74 | MP0002396_abnormal_hematopoietic_system | 0.93739152 |
| 75 | MP0009763_increased_sensitivity_to | 0.91876087 |
| 76 | MP0004808_abnormal_hematopoietic_stem | 0.90179772 |
| 77 | MP0003806_abnormal_nucleotide_metabolis | 0.88616204 |
| 78 | MP0009765_abnormal_xenobiotic_induced | 0.85655561 |
| 79 | MP0001663_abnormal_digestive_system | 0.84812577 |
| 80 | MP0005390_skeleton_phenotype | 0.84454454 |
| 81 | MP0002138_abnormal_hepatobiliary_system | 0.80236764 |
| 82 | MP0003045_fibrosis | 0.77119295 |
| 83 | MP0003646_muscle_fatigue | 0.76756903 |
| 84 | MP0000015_abnormal_ear_pigmentation | 0.74106663 |
| 85 | MP0002254_reproductive_system_inflammat | 0.72662323 |
| 86 | MP0000249_abnormal_blood_vessel | 0.66612347 |
| 87 | MP0008874_decreased_physiological_sensi | 0.64783583 |
| 88 | MP0003453_abnormal_keratinocyte_physiol | 0.63001413 |
| 89 | MP0002933_joint_inflammation | 0.61927128 |
| 90 | MP0000371_diluted_coat_color | 0.60426909 |
| 91 | MP0003795_abnormal_bone_structure | 0.59850167 |
| 92 | MP0002166_altered_tumor_susceptibility | 0.58875771 |
| 93 | MP0003221_abnormal_cardiomyocyte_apopto | 0.57456849 |
| 94 | MP0005535_abnormal_body_temperature | 0.56887710 |
| 95 | MP0000920_abnormal_myelination | 0.56861315 |
| 96 | MP0005075_abnormal_melanosome_morpholog | 0.55245033 |
| 97 | MP0001873_stomach_inflammation | 0.54795946 |
| 98 | MP0004130_abnormal_muscle_cell | 0.54115058 |
| 99 | MP0005319_abnormal_enzyme/_coenzyme | 0.53417472 |
| 100 | MP0002693_abnormal_pancreas_physiology | 0.53277376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 5.92625576 |
| 2 | Myositis (HP:0100614) | 5.84927275 |
| 3 | Orchitis (HP:0100796) | 5.81594177 |
| 4 | Recurrent abscess formation (HP:0002722) | 5.77728435 |
| 5 | Eczematoid dermatitis (HP:0000976) | 5.77146896 |
| 6 | Optic neuritis (HP:0100653) | 5.75839560 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 5.75839560 |
| 8 | Abnormality of macrophages (HP:0004311) | 5.31771393 |
| 9 | Stomatitis (HP:0010280) | 5.31668909 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.64802917 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.62968456 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 4.11439102 |
| 13 | Recurrent fungal infections (HP:0002841) | 4.09955709 |
| 14 | Keratoconjunctivitis sicca (HP:0001097) | 4.09724586 |
| 15 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.89777124 |
| 16 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.89777124 |
| 17 | Abnormality of glycolipid metabolism (HP:0010969) | 3.89777124 |
| 18 | Keratoconjunctivitis (HP:0001096) | 3.84534483 |
| 19 | Recurrent skin infections (HP:0001581) | 3.82127308 |
| 20 | Obstructive lung disease (HP:0006536) | 3.61039893 |
| 21 | Chronic obstructive pulmonary disease (HP:0006510) | 3.61039893 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.58283510 |
| 23 | Encephalitis (HP:0002383) | 3.58133755 |
| 24 | Gastrointestinal infarctions (HP:0005244) | 3.56911241 |
| 25 | Meningitis (HP:0001287) | 3.52829454 |
| 26 | Vasculitis (HP:0002633) | 3.46977957 |
| 27 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.41819608 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 3.41819608 |
| 29 | Increased cerebral lipofuscin (HP:0011813) | 3.41423905 |
| 30 | Hemoptysis (HP:0002105) | 3.21965858 |
| 31 | T lymphocytopenia (HP:0005403) | 3.21803221 |
| 32 | Spontaneous hematomas (HP:0007420) | 3.20624650 |
| 33 | Gingivitis (HP:0000230) | 3.19047245 |
| 34 | Pulmonary infiltrates (HP:0002113) | 3.15302745 |
| 35 | Abnormality of T cell number (HP:0011839) | 3.14194739 |
| 36 | Urticaria (HP:0001025) | 3.09943486 |
| 37 | Leukocytosis (HP:0001974) | 3.06259712 |
| 38 | Arterial thrombosis (HP:0004420) | 3.03755437 |
| 39 | Autoimmune thrombocytopenia (HP:0001973) | 2.99200077 |
| 40 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.94189299 |
| 41 | Recurrent viral infections (HP:0004429) | 2.93449457 |
| 42 | Increased IgE level (HP:0003212) | 2.92746118 |
| 43 | Episodic fever (HP:0001954) | 2.90095727 |
| 44 | Prolonged bleeding time (HP:0003010) | 2.86836176 |
| 45 | Chest pain (HP:0100749) | 2.79629314 |
| 46 | Amyloidosis (HP:0011034) | 2.78955447 |
| 47 | Gangrene (HP:0100758) | 2.75199052 |
| 48 | Gingival bleeding (HP:0000225) | 2.70532176 |
| 49 | Loss of speech (HP:0002371) | 2.69601747 |
| 50 | Anorexia (HP:0002039) | 2.69536649 |
| 51 | Pulmonary embolism (HP:0002204) | 2.63715412 |
| 52 | Increased IgM level (HP:0003496) | 2.61658683 |
| 53 | Vacuolated lymphocytes (HP:0001922) | 2.60536182 |
| 54 | Epistaxis (HP:0000421) | 2.53044921 |
| 55 | Abnormality of T cells (HP:0002843) | 2.51310826 |
| 56 | Dysostosis multiplex (HP:0000943) | 2.51278104 |
| 57 | Petechiae (HP:0000967) | 2.47661073 |
| 58 | Cellulitis (HP:0100658) | 2.46710270 |
| 59 | Disinhibition (HP:0000734) | 2.42310921 |
| 60 | Abnormality of the pleura (HP:0002103) | 2.41724772 |
| 61 | Granulocytopenia (HP:0001913) | 2.37419316 |
| 62 | Peritonitis (HP:0002586) | 2.36961568 |
| 63 | Increased serum ferritin (HP:0003281) | 2.36702207 |
| 64 | Pustule (HP:0200039) | 2.35779747 |
| 65 | Inflammation of the large intestine (HP:0002037) | 2.35090505 |
| 66 | Hematochezia (HP:0002573) | 2.34524189 |
| 67 | Vertigo (HP:0002321) | 2.31407792 |
| 68 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.30135947 |
| 69 | Polyneuropathy (HP:0001271) | 2.27405843 |
| 70 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.26868076 |
| 71 | Systemic lupus erythematosus (HP:0002725) | 2.25180474 |
| 72 | Panhypogammaglobulinemia (HP:0003139) | 2.25171639 |
| 73 | Eosinophilia (HP:0001880) | 2.24845100 |
| 74 | Autoimmune hemolytic anemia (HP:0001890) | 2.24024495 |
| 75 | Keratitis (HP:0000491) | 2.18915199 |
| 76 | Gastrointestinal inflammation (HP:0004386) | 2.18663073 |
| 77 | Abnormality of the endocardium (HP:0004306) | 2.17162542 |
| 78 | Osteomyelitis (HP:0002754) | 2.15617445 |
| 79 | Abnormality of iron homeostasis (HP:0011031) | 2.15398228 |
| 80 | Hypergammaglobulinemia (HP:0010702) | 2.15389245 |
| 81 | Hypochromic anemia (HP:0001931) | 2.10847320 |
| 82 | Purpura (HP:0000979) | 2.06236756 |
| 83 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.04594512 |
| 84 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.04594512 |
| 85 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.04594512 |
| 86 | Acne (HP:0001061) | 2.04206383 |
| 87 | Abnormality of T cell physiology (HP:0011840) | 2.03251088 |
| 88 | Colitis (HP:0002583) | 2.03192313 |
| 89 | Sepsis (HP:0100806) | 2.03052747 |
| 90 | Glomerulopathy (HP:0100820) | 1.98994177 |
| 91 | Hypochromic microcytic anemia (HP:0004840) | 1.97622835 |
| 92 | Abnormality of the pericardium (HP:0001697) | 1.94783086 |
| 93 | Abnormality of eosinophils (HP:0001879) | 1.90486513 |
| 94 | Mutism (HP:0002300) | 1.89448387 |
| 95 | Abnormality of the peritoneum (HP:0002585) | 1.88433213 |
| 96 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88164946 |
| 97 | Chronic otitis media (HP:0000389) | 1.86794755 |
| 98 | Amaurosis fugax (HP:0100576) | 1.85078295 |
| 99 | Hepatosplenomegaly (HP:0001433) | 1.84907359 |
| 100 | Mucopolysacchariduria (HP:0008155) | 1.83829996 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.61485029 |
| 2 | BLK | 3.43176411 |
| 3 | MAP4K1 | 3.26361204 |
| 4 | IRAK4 | 3.09639736 |
| 5 | TYK2 | 2.75049853 |
| 6 | CSK | 2.71055560 |
| 7 | MAP3K14 | 2.63422911 |
| 8 | MAP2K3 | 2.61028787 |
| 9 | TXK | 2.29470039 |
| 10 | FES | 2.18790222 |
| 11 | IRAK3 | 2.04906563 |
| 12 | FGR | 2.04485347 |
| 13 | IKBKE | 2.01705563 |
| 14 | JAK3 | 1.99981069 |
| 15 | MATK | 1.97164003 |
| 16 | ERN1 | 1.95273897 |
| 17 | TAOK3 | 1.94404101 |
| 18 | ZAP70 | 1.92688812 |
| 19 | TBK1 | 1.82139245 |
| 20 | SYK | 1.75958695 |
| 21 | PRPF4B | 1.75670479 |
| 22 | TAOK1 | 1.71737763 |
| 23 | MAP3K3 | 1.70734273 |
| 24 | TNK2 | 1.63823665 |
| 25 | MAP3K11 | 1.61400324 |
| 26 | BMPR2 | 1.60514800 |
| 27 | IKBKB | 1.59069982 |
| 28 | BTK | 1.58387461 |
| 29 | IRAK1 | 1.52853297 |
| 30 | GRK7 | 1.51979979 |
| 31 | HCK | 1.51124620 |
| 32 | GRK6 | 1.49161596 |
| 33 | KIT | 1.46741438 |
| 34 | LYN | 1.45928114 |
| 35 | EPHB1 | 1.41031069 |
| 36 | JAK2 | 1.38781936 |
| 37 | JAK1 | 1.36570503 |
| 38 | MAP3K13 | 1.33012661 |
| 39 | CSF1R | 1.30727068 |
| 40 | MAP3K1 | 1.27034367 |
| 41 | TAOK2 | 1.23494461 |
| 42 | LCK | 1.15813352 |
| 43 | TGFBR2 | 1.11152488 |
| 44 | MARK3 | 1.09171682 |
| 45 | FRK | 1.07673701 |
| 46 | IRAK2 | 1.06965855 |
| 47 | TEC | 0.98171514 |
| 48 | ACVR1B | 0.96794099 |
| 49 | SIK3 | 0.94417140 |
| 50 | ITK | 0.93328944 |
| 51 | CDC42BPA | 0.93013415 |
| 52 | YES1 | 0.87906468 |
| 53 | ADRBK2 | 0.84556036 |
| 54 | STK10 | 0.84178943 |
| 55 | PIK3CG | 0.84049627 |
| 56 | DAPK2 | 0.78504000 |
| 57 | KSR2 | 0.76599981 |
| 58 | PDK1 | 0.76119673 |
| 59 | MAP3K5 | 0.76071550 |
| 60 | CHUK | 0.74020063 |
| 61 | MARK2 | 0.72415116 |
| 62 | PIM1 | 0.66425019 |
| 63 | EPHA3 | 0.65712911 |
| 64 | MAP3K6 | 0.64447142 |
| 65 | MAP2K6 | 0.61801031 |
| 66 | SIK2 | 0.60727897 |
| 67 | PDPK1 | 0.59263720 |
| 68 | CAMKK2 | 0.57878763 |
| 69 | MAP3K2 | 0.54207394 |
| 70 | MOS | 0.54206414 |
| 71 | PTK2B | 0.52901914 |
| 72 | HIPK2 | 0.52173460 |
| 73 | FYN | 0.49978245 |
| 74 | PRKCQ | 0.49526407 |
| 75 | MAPK7 | 0.48520547 |
| 76 | DYRK3 | 0.48304977 |
| 77 | PRKD2 | 0.47727582 |
| 78 | FGFR3 | 0.44308074 |
| 79 | RPS6KA6 | 0.41760455 |
| 80 | SGK3 | 0.40816931 |
| 81 | RPS6KL1 | 0.40807988 |
| 82 | RPS6KC1 | 0.40807988 |
| 83 | MAPK12 | 0.40779552 |
| 84 | STK11 | 0.40767735 |
| 85 | PTK6 | 0.38673017 |
| 86 | NLK | 0.38210078 |
| 87 | CAMK1D | 0.36570624 |
| 88 | SGK2 | 0.36258383 |
| 89 | MAP3K7 | 0.35198393 |
| 90 | MAP2K4 | 0.34931690 |
| 91 | ABL1 | 0.33515510 |
| 92 | PRKAA2 | 0.31192675 |
| 93 | LRRK2 | 0.30495175 |
| 94 | DYRK1B | 0.30009102 |
| 95 | MAPKAPK2 | 0.29161830 |
| 96 | WNK1 | 0.28839232 |
| 97 | TESK2 | 0.28526325 |
| 98 | RAF1 | 0.28149256 |
| 99 | DDR2 | 0.25708119 |
| 100 | KSR1 | 0.25267890 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.10009998 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.99877953 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.94401649 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.46364458 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.45609875 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.45118797 |
| 7 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.42278311 |
| 8 | Tuberculosis_Homo sapiens_hsa05152 | 2.31180434 |
| 9 | Malaria_Homo sapiens_hsa05144 | 2.17119578 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.16323370 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.12118244 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.10843119 |
| 13 | Legionellosis_Homo sapiens_hsa05134 | 2.00108837 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.95967369 |
| 15 | Asthma_Homo sapiens_hsa05310 | 1.90150098 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.85234042 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.83829455 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.82499008 |
| 19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.80313745 |
| 20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.79981626 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.75537787 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.73825142 |
| 23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.68106414 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.66623257 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.65580413 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.63682268 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.61903077 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.59491910 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.55123917 |
| 30 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.53621113 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.53522199 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.53228891 |
| 33 | Pertussis_Homo sapiens_hsa05133 | 1.52761045 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.48373204 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.43029637 |
| 36 | Lysosome_Homo sapiens_hsa04142 | 1.41334015 |
| 37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.38584859 |
| 38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.35746644 |
| 39 | Phagosome_Homo sapiens_hsa04145 | 1.34460743 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.30702231 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.26669726 |
| 42 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.24671925 |
| 43 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.22416170 |
| 44 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.18032461 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 1.16849466 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 1.12800629 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.09921228 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 1.09319301 |
| 49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05035240 |
| 50 | Platelet activation_Homo sapiens_hsa04611 | 0.98796529 |
| 51 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.93800418 |
| 52 | Shigellosis_Homo sapiens_hsa05131 | 0.88711629 |
| 53 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.87407274 |
| 54 | Apoptosis_Homo sapiens_hsa04210 | 0.85872305 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84485536 |
| 56 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.83620146 |
| 57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.82180142 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.75818536 |
| 59 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72166236 |
| 60 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72044865 |
| 61 | Amoebiasis_Homo sapiens_hsa05146 | 0.70785174 |
| 62 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.68843387 |
| 63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.68219809 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66553044 |
| 65 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66482257 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.65477781 |
| 67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62125624 |
| 68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61831146 |
| 69 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.60084768 |
| 70 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59371484 |
| 71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54148056 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53911606 |
| 73 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.53347434 |
| 74 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53009002 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51364987 |
| 76 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49837607 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48798114 |
| 78 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.45909437 |
| 79 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43278399 |
| 80 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43261165 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43041827 |
| 82 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.42949497 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.42156174 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.40874594 |
| 85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.39376437 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38641354 |
| 87 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.38052432 |
| 88 | HTLV-I infection_Homo sapiens_hsa05166 | 0.37166382 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.35338535 |
| 90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35165257 |
| 91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34518878 |
| 92 | Bladder cancer_Homo sapiens_hsa05219 | 0.34397974 |
| 93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.30610353 |
| 94 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.29834238 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.29700405 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.29032158 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25638194 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.21685530 |
| 99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.20035076 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.19901332 |

